Nanoparticle Diagnostics and Theranostics in the Clinic

Roger M Pallares; Felix M Mottaghy; Volkmar Schulz; Fabian Kiessling; Twan Lammers

doi:10.2967/jnumed.122.263895

Nanoparticle Diagnostics and Theranostics in the Clinic

Roger M Pallares^*, Felix M Mottaghy, Volkmar Schulz, Fabian Kiessling, Twan Lammers

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Nanoparticles possess unique features that may be useful for disease diagnosis and therapy. Preclinically, many different nanodiagnostics have been explored, but only a few have made it to the market. We here provide an overview of nanoparticle-based imaging agents currently used and evaluated in the clinic and discuss preclinical progress and translational avenues for the use of nanoparticles for diagnostic and theranostic applications.

Original language	English
Pages (from-to)	1802-1808
Number of pages	7
Journal	Journal of Nuclear Medicine
Volume	63
Issue number	12
DOIs	https://doi.org/10.2967/jnumed.122.263895
Publication status	Published - 1 Dec 2022

Keywords

Humans
Theranostic Nanomedicine/methods
Precision Medicine/methods
Nanoparticles/therapeutic use
Neoplasms/therapy

Access to Document

10.2967/jnumed.122.263895

Cite this

@article{b1eecf45c20f4338869b1c0d52a9d562,

title = "Nanoparticle Diagnostics and Theranostics in the Clinic",

abstract = "Nanoparticles possess unique features that may be useful for disease diagnosis and therapy. Preclinically, many different nanodiagnostics have been explored, but only a few have made it to the market. We here provide an overview of nanoparticle-based imaging agents currently used and evaluated in the clinic and discuss preclinical progress and translational avenues for the use of nanoparticles for diagnostic and theranostic applications.",

keywords = "Humans, Theranostic Nanomedicine/methods, Precision Medicine/methods, Nanoparticles/therapeutic use, Neoplasms/therapy",

author = "Pallares, {Roger M} and Mottaghy, {Felix M} and Volkmar Schulz and Fabian Kiessling and Twan Lammers",

note = "{\textcopyright} 2022 by the Society of Nuclear Medicine and Molecular Imaging.",

year = "2022",

month = dec,

day = "1",

doi = "10.2967/jnumed.122.263895",

language = "English",

volume = "63",

pages = "1802--1808",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine and Molecular Imaging",

number = "12",

}

TY - JOUR

T1 - Nanoparticle Diagnostics and Theranostics in the Clinic

AU - Pallares, Roger M

AU - Mottaghy, Felix M

AU - Schulz, Volkmar

AU - Kiessling, Fabian

AU - Lammers, Twan

PY - 2022/12/1

Y1 - 2022/12/1

N2 - Nanoparticles possess unique features that may be useful for disease diagnosis and therapy. Preclinically, many different nanodiagnostics have been explored, but only a few have made it to the market. We here provide an overview of nanoparticle-based imaging agents currently used and evaluated in the clinic and discuss preclinical progress and translational avenues for the use of nanoparticles for diagnostic and theranostic applications.

AB - Nanoparticles possess unique features that may be useful for disease diagnosis and therapy. Preclinically, many different nanodiagnostics have been explored, but only a few have made it to the market. We here provide an overview of nanoparticle-based imaging agents currently used and evaluated in the clinic and discuss preclinical progress and translational avenues for the use of nanoparticles for diagnostic and theranostic applications.

KW - Humans

KW - Theranostic Nanomedicine/methods

KW - Precision Medicine/methods

KW - Nanoparticles/therapeutic use

KW - Neoplasms/therapy

U2 - 10.2967/jnumed.122.263895

DO - 10.2967/jnumed.122.263895

M3 - Article

C2 - 36302654

SN - 0161-5505

VL - 63

SP - 1802

EP - 1808

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 12

ER -